Learn More
Medchemexpress LLC Doxazosin | 74191-85-8 | 99.9% | C23H25N5O5 | 1 ML

Supplier: Medchemexpress LLC HYB009810MM/1ML
Doxazosin (UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors. It is for research use only and not sold to patients.
- Selectively antagonizes postsynaptic α1-adrenergic receptors
- Functions as a long-lasting inhibitor of α1-adrenoceptors
- Used to treat benign prostatic hyperplasia and lower urinary tract symptoms
- May directly inhibit cholesterol synthesis independently of the LDL receptor
- Shown effectiveness in monotherapy and combined therapy with a beta-blocker in clinical observations
- Exhibits minor and transient adverse reactions in some cases
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.